Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy

Circulation

Volumn 110, Issue 16, 2004, Pages 2336-2341

  Lima, João A C ^a,b,c   Desai, Milind Y ^a   Steen, Henning ^a   Warren, William P ^a   Gautam, Sandeep ^a   Lai, Shenghan ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Atherosclerosis; Lipids; Magnetic resonance imaging; Plaque

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTERY OCCLUSION; ARTICLE; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DOSE TIME EFFECT RELATION; EARLY DIAGNOSIS; FEMALE; HEART VENTRICLE REMODELING; HUMAN; HYPERCHOLESTEROLEMIA; MALE; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; OUTCOMES RESEARCH; PATIENT MONITORING; PRIORITY JOURNAL; REGRESSION ANALYSIS; REPRODUCIBILITY; STATISTICAL SIGNIFICANCE;

AGED; AORTA, THORACIC; AORTIC DISEASES; ARTERIOSCLEROSIS; CEREBROVASCULAR ACCIDENT; CHOLESTEROL, LDL; COMORBIDITY; CORONARY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBSERVER VARIATION; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SIMVASTATIN; SMOKING;

EID: 6444234851     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000145170.22652.51     Document Type: Article

References (33)

1. Michaud CM, Murray CJL, Bloon BR. Burden of disease: implications for future research. JAMA. 2001:285:535-539.
2. The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
3. Cholesterol and Recurrent Events (CARE) Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335:1001-1009.
4. Shepherd J, Cobbe SM, Ford I, et al, for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301-1307.
5. Downs JR, Clearfield M, Weiss S, et al, for the AFCAPS/TexCAPS. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998;279:1615-1622.
6. Brown BG, Zhao XQ, Chait A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001;345:1585-1592.
7. Genest J, Pedersen TR. Prevention of cardiovascular ischemic events: high-risk and secondary prevention. Circulation. 2003;107:2059-2065.
8. Pitt B, Mancini GB, Ellis SG, et al. Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC-1): reduction in atherosclerosis progression and clinical events. J Am Coll Cardiol. 1995;26:1133-1139.
9. Redberg R, Vogel F, Criqui M, et al. Task Force # 3: what is the spectrum of current and emerging techniques for the non-invasive measurement of atherosclerosis? J Am Coll Cardiol. 2003;41:1886-1896.
10. Nolting PRW, de Groot E, Zwinderman AH, et al. Regression of carotid and femoral artery intima-media thickness in familial hypercholesterolemia. Arch Intern Med. 2003;163:1837-1841.
11. Mercuri M, Bond MG, Sirtori CR. et al. Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic Mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study. Am J Med. 1996;191:627-634.
12. Tagaki T, Yoshida K, Akasaka T, et al. Intravascular ultrasound analysis of reduction in progression of coronary narrowing by treatment with pravastatin. Am J Cardiol. 1997;79:1673-1677.
13. Corti R, Fuster V, Fayad ZA, et al. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution non-invasive magnetic resonance imaging. Circulation. 2002;106:2884-2887.
14. Crisby M, Nordin-Fredriksson G, Shah PK, et al. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation. 2001;103:926-933.
15. Nissen SE, Tsunoda T, Tuzcu EM, et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes. JAMA. 2003;290:2292-2300.
16. de Groot E, Jukema JW, van Swijndregt ADM. et al. B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS). J Am Coll Cardiol. 1998;31:1561-1567.
17. Wiklund O, Hulthe J, Wikstrand J, et al. Effect of controlled release/ extended release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia: a 3-year randomised study. Stroke. 2002;33:572-577.
18. Simon A, Gariepy J, Chironi G, et al. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens. 2002;20:159-169.
19. Fang JC, Kinlay S, Beltrane J, et al. Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial. Lancet. 2002;359:1108-1113.
20. Schwartz GG, Olsson AG, Ezekowitz MD, et al, for the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Effect of atorvastatin on early recurrent ischemic events in acute coronary syndromes. JAMA. 2001;285:1711-1718.
21. McConnell MV, Aikawa M, Maier SE, et al. MRI of rabbit atherosclerosis in response to dietary cholesterol lowering. Arterioscler Thromb Vasc Biol. 1999;19:1956-1959.
22. Yuan C, Beach KW, Smith LH Jr, et al. Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. Circulation. 1998;98:2666-2671.
23. Shunk KA, Lima JA, Heldman AW, et al. Transesophageal magnetic resonance imaging. Magn Reson Med. 1999;41:722-726.
24. Shunk KA, Garot J, Atalar E, et al. Transesophageal magnetic resonance imaging of the aortic arch and descending thoracic aorta in patients with aortic atherosclerosis. J Am Coll Cardiol. 2001;37:2031-2035.
25. Fleiss JL. The Design and Analysis of Clinical Experiments. New York, NY: Wiley; 1986:8-14.
26. Rosner B. Fundamentals of Biostatistics. Belmont, Calif: Duxbury Press; 1995:322-328.
27. Ubels FL, Muntinga JH, van Doormaal JJ, et al. Effects of initial and long-term lipid-lowering therapy on vascular wall characteristics. Atherosclerosis. 2001;20:159-169.
28. Armstrong ML, Megan MB. Arterial fibrous protein in cynomolgus monkeys after atherogenic and regression diets. Circ Res. 1975;36:256-261.
29. Clarkson TB, Bond MG, Bullock BC, et al. A study of atherosclerosis regression in Macaca mulatta, IV: changes in coronary arteries from animals with atherosclerosis induced for 19 months and then regressed for 24 or 48 months at plasma cholesterol concentrations of 300 or 200 mg/dl. Exp Mol Pathol. 1981;34:345-368.
30. Small DM, Bond MG, Waugh D, et al. Physiochemical and histological changes in the arterial wall of nonhuman primates during progression and regression of atherosclerosis. J Clin Invest. 1984;73:1590-1605.
31. Sukhova GK, Shi GP, Simon DI, et al. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest. 1998;102:576-583.
32. Glagov S, Weisenberg E, Zarins CK, et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316:1371-1375.
33. Warren WP, Heath S, Lima JAC. Combined transesophageal and surface MRI provides optimal imaging of aortic atherosclerosis. J Am Coll Cardiol. 2003;41:458A. Abstract.